Congenital Hyperinsulinism
Showing 1 - 25 of 1,813
Congenital Hyperinsulinism, Insulinoma Trial in Fort Worth (Fluorodopa F 18)
Recruiting
- Congenital Hyperinsulinism
- Insulinoma
- Fluorodopa F 18
-
Fort Worth, TexasCook Children's Medical Center
Dec 8, 2022
Congenital Hyperinsulinism Trial in Worldwide (dasiglucagon)
Enrolling by invitation
- Congenital Hyperinsulinism
-
Aurora, Colorado
- +9 more
Jan 30, 2023
Congenital Hyperinsulinism Trial in Worldwide (dasiglucagon, Standard of Care)
Completed
- Congenital Hyperinsulinism
- dasiglucagon
- Standard of Care
-
Aurora, Colorado
- +9 more
Jan 31, 2023
Congenital Hyperinsulinism Trial in Worldwide (dasiglucagon, Placebo)
Completed
- Congenital Hyperinsulinism
- dasiglucagon
- Placebo
-
Philadelphia, Pennsylvania
- +5 more
Mar 31, 2022
Congenital Hyperinsulinism Trial in Worldwide (RZ358 Sequential Group Cohort 1, RZ358 Sequential Group Cohort 2, RZ358
Completed
- Congenital Hyperinsulinism
- RZ358 Sequential Group Cohort 1
- +3 more
-
Philadelphia, Pennsylvania
- +16 more
Sep 7, 2022
Congenital Hyperinsulinism, Neuroblastoma, Parkinson Disease Trial in Edmonton (18F-DOPA, Furosemide Injection)
Recruiting
- Congenital Hyperinsulinism
- +5 more
- 18F-DOPA
- Furosemide Injection
-
Edmonton, Alberta, CanadaWC Mackenzie Health Science Centre / University of Alberta Hospi
Apr 11, 2022
Obesity, Hypoglycemia Post Gastric Bypass Surgery, Hyperinsulinemic Hypoglycemia Trial in Arnhem (GLP-1R PET)
Recruiting
- Obesity
- +2 more
- GLP-1R PET
-
Arnhem, NetherlandsRijnstate hospital
Oct 27, 2022
Congenital Hyperinsulinism (CHI), Persistent Hyperinsulinemic Hypoglycemia of Infancy (PHHI) Trial in Philadelphia (18 F-DOPA)
Completed
- Congenital Hyperinsulinism (CHI)
- Persistent Hyperinsulinemic Hypoglycemia of Infancy (PHHI)
- 18 F-DOPA
-
Philadelphia, PennsylvaniaThe Children's Hospital of Philadelphia
Oct 14, 2021
Congenital Hyperinsulinism, Insulinoma, Hyperinsulinism Trial (Pasireotide 0.6Mg Solution for Injection, Saline Solution)
Withdrawn
- Congenital Hyperinsulinism
- +2 more
- Pasireotide 0.6Mg Solution for Injection
- Saline Solution
- (no location specified)
May 12, 2021
Octreotide in the Treatment of Congenital Hyperinsulinemia
Completed
- Congenital Hyperinsulinaemic Hypoglycaemia
- Octreotide Adverse Reaction
- Octreotide Injection
-
Beijing, Beijing, ChinaDepartment of Endocrinology, Genetics, Metabolism
Dec 19, 2021
Acquired Hyperinsulinemic Hypoglycemia Trial in Palo Alto (Avexitide)
Recruiting
- Acquired Hyperinsulinemic Hypoglycemia
-
Palo Alto, CaliforniaClinical and Translational Research Unit
Mar 31, 2022
Hyperinsulinemic Hypoglycemia, Postprandial Hypoglycemia Trial in Hellerup (Dasiglucagon, HyoPen, Placebo)
Recruiting
- Hyperinsulinemic Hypoglycemia
- Postprandial Hypoglycemia
- Dasiglucagon
- +2 more
-
Hellerup, DenmarkCenter for Clinical Metabolic Research, Herlev-Gentofte Hospital
Sep 28, 2021
Endogenous Hyperinsulinism Trial in Basel (Exenatide, 0.9% saline solution)
Recruiting
- Endogenous Hyperinsulinism
- Exenatide
- 0.9% saline solution
-
Basel, SwitzerlandUniversity Hospital Basel, Division of Nuclear Medicine
May 31, 2021
Neuro-endocrine Response to Post-prandial Hyperinsulinaemic
Completed
- Roux-en-y Gastric Bypass
- Post Prandial Hypoglycemia
- Administration of glucose and controlled induction of hypoglycaemia.
-
Bern, SwitzerlandDepartment of Diabetes, Endocrinology, Nutritional Medicine and
Aug 9, 2021
Hyperinsulinism, Diabetes, Pancreatic Diseases Trial in Philadelphia (Bihormonal Bionic Pancreas)
Completed
- Hyperinsulinism
- +3 more
- Bihormonal Bionic Pancreas
-
Philadelphia, PennsylvaniaChildren's Hospital of Philadelphia
Oct 2, 2020
Hyperinsulinemic Hypoglycemia, Persistent, Congenital Hyperinsulinism, Persistent Hyperinsulinemic Hypoglycemia of Infancy
No longer available
- Hyperinsulinemic Hypoglycemia, Persistent
- +2 more
- 18 F-DOPA
-
Houston, TexasTexas Children's Hospital
Sep 3, 2020
Postprandial Hypoglycemia Trial in Barcelona (Canagliflozin 300 MG Oral Tablet)
Unknown status
- Postprandial Hypoglycemia
- Canagliflozin 300 MG Oral Tablet
-
Barcelona, SpainAndreea Ciudin
Jan 26, 2021
Roux-en-Y Gastric Bypass, Postprandial Hypoglycemia, Driving Impaired Trial in Bern (Oral glucose tolerance test, Ingestion of )
Completed
- Roux-en-Y Gastric Bypass
- +2 more
- Oral glucose tolerance test
- Ingestion of placebo
-
Bern, SwitzerlandDepartment of Diabetes, Endocrinology, Clinical Nutrition and Me
Feb 17, 2021
Congenital Hyperinsulinism Trial in Philadelphia (Exendin-(9-39), )
Completed
- Congenital Hyperinsulinism
- Exendin-(9-39)
- placebo
-
Philadelphia, PennsylvaniaThe Children's Hospital of Philadelphia
Mar 12, 2020
Post-Bariatric Hypoglycemia Trial in Stanford (Use of Continuous Glucose Monitor (CGM), Use of Cardea Solo monitoring)
Unknown status
- Post-Bariatric Hypoglycemia
- Use of Continuous Glucose Monitor (CGM)
- Use of Cardea Solo monitoring
-
Stanford, CaliforniaStanford University School of Medicine
Oct 29, 2020
Baby Detect : Genomic Newborn Screening
Recruiting
- Congenital Adrenal Hyperplasia
- +126 more
-
Liege, Wallonia, BelgiumCRMN, Hôpital La Citadelle
Jan 24, 2023
Congenital Hyperinsulinism, Hyperinsulinism, Persistent Hyperinsulinemic Hypoglycemia of Infancy Trial in Philadelphia (F-DOPA,
Completed
- Congenital Hyperinsulinism
- +4 more
- F-DOPA
- PET scan
-
Philadelphia, PennsylvaniaChildren's Hospital of Philadelphia
Feb 26, 2020
Hyperinsulinism-Hyperammonemia Syndrome Trial in Philadelphia (Vitamin E)
Not yet recruiting
- Hyperinsulinism-Hyperammonemia Syndrome
- Vitamin E
-
Philadelphia, PennsylvaniaChildren's Hospital of Philadelphia
Aug 17, 2022
Hyperinsulinemic Hypoglycemia Trial in United States (Glucagon RTU, Placebo)
Completed
- Hyperinsulinemic Hypoglycemia
- Glucagon RTU
- Placebo
-
Aurora, Colorado
- +4 more
May 20, 2020